MoneyWorks4Me

Solara Active Pharma Sciences informs about clarification on significant increase in volume

27 Jun 2022 Evaluate

Solara Active Pharma Sciences has clarified that Company has made all the required disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that, in its opinion, would have a bearing on the price/volume behaviour in the scrip.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..